Skip to main content
. 2022 Oct 21;23(20):12667. doi: 10.3390/ijms232012667

Table 5.

Characteristics of patients treated with anti-TNF.

Author, Year, [Ref.] Patient’s Features Type AIP IBD Treatment at AIP Recurrence Anti TNF Therapy
Lorenzo D et al., 2020 [93] Woman, 28 years old AIP type 2 Negative for IBD Rituximab Adalimumab
Lorenzo D et al., 2020 [93] Woman, 16 years old AIP type 2 Ulcerative colitis / Adalimumab
Lorenzo D et al., 2020 [93] Woman, 38 years old AIP type 2 Crohn disease Azathioprine and then methotrexate Infliximab
Lorenzo D et al., 2020 [93] Woman, 18 years old AIP type 2 Crohn disease Azathioprine Adalimumab
Naghibi M et al., 2013 [94] Woman, 16 years old AIP type 1 IgG4 positive colitis Azathioprine and then infliximab Adalimumab

AIP: autoimmune pancreatitis; IBD: Inflammatory Bowel Disease; Anti TNF: anti Anti-Tumor Necrosis Factor; IgG4: Immunoglobulin G4.